Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

FLEX MALDI-TOF

By Drug Discovery Trends Editor | June 2, 2010

Bruker launched the newest member in the successful FLEX series of MALDI-TOF mass spectrometers, the autoflex speed. The autoflex speed delivers superior performance by incorporating numerous innovative technology advancements which provide further enhanced data quality, acquisition speed, class-leading mass and dynamic range, and general robust and efficient performance.

The autoflex speed utilizes a 1 kHz smartbeam-II laser, wide mass range resolving power of up to 26,000 using PAN technology, a novel FlashDetector system, and a 4 Gs/s digitizer to enable class-leading performance for challenging applications.

The new FAST-SRM mode also provides the autoflex speed with single reaction monitoring capabilities to enhance results for drug imaging in tissues on a MALDI platform. Finally, the autoflex speed achieves the full potential of Edmass top-down, intact protein sequencing for long sequence readouts including incorporation of Bruker’s patented T³-Sequencing technology.

System configurations can be optimized for a number of different analytical operations and environments utilizing both TOF and TOF/TOF modes for a variety of proteomics, imaging, polymer and small molecule applications.

By leveraging Bruker’s long-standing expertise in high-performance MALDI-TOF mass spectrometry the autoflex speed is designed to dramatically enhance the productivity of laboratories involved in protein sequencing, biomarker discovery, polymer analysis, lipid and glycan analysis, molecular imaging, drug and metabolite tissue distribution, as well as high-throughput MALDI Biotyper microbiological molecular identification. The autoflex speed complements Bruker’s ultimate performance MALDI-TOF/TOF system, the ultrafleXtreme.

The autoflex speed incorporates a number of key features which enhance its capabilities and value including:

    * Enhanced Speed with a 1 kHz (kiloHertz) proprietary smartbeam-II solid-state laser and electronics for high throughput applications including LC-MALDI, MALDI Imaging, and high-throughput microbiology ID,
    * Unique FAST-SRM mode provides single reaction monitoring capabilities for imaging of drugs and metabolites in tissue,
    * Expanded High-Resolution Mass Range for analysis of polymers and Edmass top-down, intact protein sequencing for long sequence readouts,
    * FlashDetector technology to increase resolution and prevent signal saturation for complex samples,
    * MALDI Perpetual Self-cleaning Ion Source cleans the instrument source in minutes to improve system up-time and with minimal operator maintenance,
    * Optimized Software packages for numerous applications e.g. Protein-, Peptide-, Polymer-Analyses, and MALDI Imaging, clinical research methods and the MALDI Biotyper IVD-CE workflow;

Dr. Ian Sanders, Executive Vice President at Bruker Daltonics, commented: “The new autoflex speed delivers outstanding and robust performance in a very accessible and cost effective platform. This platform can significantly increase the capabilities and effectiveness of analytical groups, particularly those working in biotherapeutics, as well as for basic proteomics and biomarker discovery research. The autoflex speed enhances the reach and capabilities of MALDI-TOF and TOF/TOF, and makes innovative technology readily available and accessible – also for non mass spec experts.”

Bruker Daltonics


Filed Under: Drug Discovery

 

Related Articles Read More >

China’s biopharma sector enters ‘innovation 2.0’ era
The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE